Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 99, Issue 19, 2002, Pages 12455-12460

  Lu, Yao Ping ^a   Lou, You Rong ^a   Xie, Jian Guo ^a   Peng, Qing Yun ^a   Liao, Jie ^a   Yang, Chung S ^a   Huang, Mou Tuan ^a   Conney, Allan H ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Caspase 3; Programmed cell death; Tea constituents

Indexed keywords

BROXURIDINE; CAFFEINE; CASPASE 3; EPIGALLOCATECHIN GALLATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SUNLIGHT; ULTRAVIOLET B RADIATION;

ADMINISTRATION, TOPICAL; ANIMALS; APOPTOSIS; BROMODEOXYURIDINE; CAFFEINE; CASPASE 3; CASPASES; CATECHIN; FEMALE; MICE; MICE, INBRED HRS; NEOPLASMS, RADIATION-INDUCED; SKIN NEOPLASMS; TEA; ULTRAVIOLET RAYS;

ANIMALIA;

EID: 0037126058     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.182429899     Document Type: Article

References (48)

1. Nataraj, A. J., Trent, J. C., II, & Ananthaswamy, H. N. (1995) Photochem. Photobiol. 62, 218-230.
2. McKenzie, R., Connor, B. & Bodeker, G. (1999) Science 285, 1709-1711.
3. Stern, R. S., Weinstein, M. C. & Baker, S. G. (1986) Arch. Dermatol. 122, 537-545.
4. Glanz, K., Saraiya, M. & Wechsler, H. (2002) Morbid. Mortal. Wkly. Rep. 51, 1-18.
5. Lou, Y.-R., Lu, Y.-P., Xie, J.-G., Huang, M.-T. & Conney, A. H. (1999) Nutr. Cancer 33, 146-153.
6. Lu, Y.-P., Lou, Y.-R., Xie, J.-G., Yen, P., Huang, M.-T. & Conney, A. H. (1997) Carcinogenesis 18, 2163-2169.
7. Bogovski, P. (1994) in Pathology of Tumors in Laboratory Animals-Vol. II: Tumors of the Mouse, eds. Turusov, V. S. & Mohr, U. (International Agency for Research on Cancer, Lyon, France), IARC Scientific Publication No. 111, pp. 1-26.
8. Lu, Y.-P., Lou, Y.-R., Lin, Y., Shih, W. J., Huang, M.-T., Yang, C. S. & Conney, A. H. (2001) Cancer Res. 61, 5002-5009.
9. Lu, Y.-P., Lou, Y.-R., Li, X. H., Xie, J.-G., Brash, D., Huang, M.-T. & Conney, A. H. (2000) Cancer Res. 60, 4785-4791.
10. Lu, Y.-P., Lou, Y.-R., Li, X. H., Xie, J.-G., Lin, Y., Shih, W. J. & Conney, A. H. (2002) Oncol. Res., in press.
11. Qi, W., Qiao, D. & Martinez, J. D. (2002) Radiat. Res. 157, 166-174.
12. Hayakawa, S., Saeki. K., Sazuka, M., Suzuki, Y., Shoji, Y., Ohta, T., Kaji, K., Yuo, A. & Isemura, M. (2001) Biochem. Biophys. Res. Commun. 285, 1102-1106.
13. Chen, Z. P., Schell, J. B., Ho, C.-T. & Chen, K. Y. (1998) Cancer Lett. 129, 173-179.
14. Yang, G. Y., Liao, J., Kim, K., Yurkow, E. J. & Yang, C. S. (1998) Carcinogenesis 19, 611-616.
15. Hakim, I. A., Harris, R. B. & Weisgerber, U. M. (2000) Cancer Epidemiol. Biomarkers Prevent. 9, 727-731.
16. Rapuri, P. B., Gallagher, J. C., Kinyamu, H. K. & Ryschon, K. L. (2001) Am. J. Clin. Nutr. 74, 694-700.
17. Massey, L. K. (2001) Am. J. Clin. Nutr. 74, 569-570.
18. Yang, C. S., Maliakal, P. & Meng, X. (2002) Annu. Rev. Pharmacol. Toxicol. 42, 25-54.
19. Katiyar, S. K., Ahmad, N. & Mukhtar, H. (2000) Arch. Dermatol. 136, 989-994.
20. Yang, C. S., Prabhu, S. & Landau, J. (2001) Drug Metab. Rev. 33, 237-253.
21. Zajdela, F. & Latarjet, R. (1973) C. R. Hebd. Seances Acad. Sci. 277, 1073-1076.
22. Zajdela, F. & Latarjet, R. (1978) Bull. Cancer 65, 305-314.
23. R0othwell, K. (1974) Nature (London) 252, 69-70.
24. Perchellet, J.-P. & Boutwell, R. K. (1981) Cancer Res. 41, 3927-3935.
25. Nomura, T. (1976) Nature (London) 260, 547-549.
26. Nomura, T. (1980) Cancer Res. 40, 1332-1340.
27. Nomura, T. (1983) Cancer Res. 43, 1342-1346.
28. Theiss, J. C. & Shimkin, M. B. (1978) Cancer Res. 38, 1757-1761.
29. VanderPloeg, L. C. & Welsch, C. W. (1991) Cancer Lett. 56, 245-250.
30. Nagasawa, H. & Konishi, R. (1988) Eur. J. Cancer Clin. Oncol. 24, 803-805.
31. Welsch, C. W., Scieszka, K. M., Senn, E. R. & DeHoog, J. V. (1983) Int. J. Cancer 32, 479-484.
32. Welsch, C. W., DeHoog, J. V. & O'Connor, D. H. (1988) Cancer Res. 48, 2078-2082.
33. Minton, J. P., Abou-Issa, H., Foecking, M. K. & Sriram, M. G. (1983) Cancer 51, 1249-1253.
34. Hiroshino, H. & Tanooka, H. (1979) Toxicol. Lett. 4, 83-85.
35. Lin, J. K., Liang, Y. C. & Lin-Shiau, S. Y. (1999) Biochem. Pharmacol. 58, 911-915.
36. Ahmad, N., Gupta, S. & Mukhtar, H. (2000) Arch. Biochem. Biophys. 376, 338-346.
37. Fujiki, H., Suganuma, M., Okabe, S., Sueoka, N., Komori, A., Sueoka, E., Kozu, T., Tada, Y., Suga, K., Imai, K. & Nakachi, K. (1998) Mutat. Res. 402, 307-310.
38. Ahmad, N., Cheng, P. & Mukhtar, H. (2000) Biochem. Biophys. Res. Commun. 275, 328-334.
39. Tan, X., Hu, D., Li, S., Han, Y., Zhang, Y. & Ahou, D. (2000) Cancer Lett. 158, 1-6.
40. Schlegel, R. & Pardee, A. B. (1986) Science 232, 1264-1266.
41. Yao, S. L., Akhtar, A. J., McKenna, K. A., Bedi, G. C., Sidransky, D., Mabry, M., Ravi, R., Collector, M. I., Jones, R. J., Sharkis, S. J., et al. (1996) Nat. Med. 2, 1140-1143.
42. Russell, K. J., Wiens, L. W., Demers, G. W., Galloway, D. A., Plon, S. E. & Groudine, M. (1995) Cancer Res. 55, 1639-1642.
43. Powell, S. N., DeFrank, J. S., Connell, P., Eogan, M., Preffer, F., Dombkowski, D., Tang, W. & Friend, S. (1995) Cancer Res. 55, 1643-1648.
44. Musk, S. R. & Steel, G. G. (1990) Int. J. Radiat. Biol. 57, 1105-1112.
45. Sarkaria, J. N., Busby, E. C., Tibbetts, R. S., Roos, P., Taya, Y., Karnitz, L. M. & Abraham, R. T. (1999) Cancer Res. 59, 4375-4382.
46. Higuchi, K., Mitsuhashi, N., Saitoh, J.-J., Maebayashi, K., Sakurai, H., Akimoto, T, & Niibe, H. (2000) Cancer Lett. 152, 157-162.
47. Nghiem, P., Park, P. K., Kim, Y.-S., Vaziri, C. & Schreiber, S. L. (2001) Proc. Natl. Acad. Sci. USA 98, 9092-9097.
48. Nghiem, P., Park, P. K., Kim, Y.-S., Desai, B. N. & Schreiber, S. L. (2002) J. Biol. Chem. 277, 4428-4434.